 NEW YORK, Jan. 23, 2020 Oramed Pharmaceuticals Inc. NASDAQ: ORMP TASE: ORMP a clinical-stage pharmaceutical company focused on the development of oral drug delivery systems, announced today the addition of Dr. Alexander Fleming to its Scientific Advisory Board. 